Literature DB >> 11775321

[Microbiological surveillance: viral hemorrhagic fever in Central African Republic: current serological data in man].

E Nakounné1, B Selekon, J Morvan.   

Abstract

An investigation was conducted between 1994 and 1997 in forested areas of the Central African Republic (CAR) to determine the seroprevalence of IgG antibodies against several haemorrhagic fever viruses present in the region. Sera were obtained from 1762 individuals in two groups (Pygmy and Bantu locuted populations) living in 4 forested areas in the south of the country. Sera were tested for IgG antibodies against Ebola, Marburg, Rift Valley fever (RVF), Yellow fever (YF) and Hantaviruses by enzyme immunoassay (EIA), and against Lassa virus by immunofluorescent assay. The prevalence of IgG antibodies was 5.9% for Ebola, 2% for Marburg, 6.9% pour RVF, 6.5% for YF, 2% for Hantaan. No antibodies were detected against Lassa, Seoul, Puumala and Thottapalayam viruses. No IgM antibodies were detected against RVF and YF viruses. The distribution of antibodies appears to be related to tropical rain forest areas. This study indicates that several haemorrhagic fever viruses are endemic in forested areas of the CAR and could emerge due to environmental modification.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11775321

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  14 in total

Review 1.  New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention--a review.

Authors:  Martin Zeier; Michaela Handermann; Udo Bahr; Baldur Rensch; Sandra Müller; Roland Kehm; Walter Muranyi; Gholamreza Darai
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

2.  Rift Valley fever virus seroprevalence in human rural populations of Gabon.

Authors:  Xavier Pourrut; Dieudonné Nkoghé; Marc Souris; Christophe Paupy; Janusz Paweska; Cindy Padilla; Ghislain Moussavou; Eric M Leroy
Journal:  PLoS Negl Trop Dis       Date:  2010-07-27

3.  Rift Valley fever in goats, Cameroon.

Authors:  Matthew LeBreton; Sally Umlauf; Cyrille F Djoko; Peter Daszak; Donald S Burke; Paul Yemgai Kwenkam; Nathan D Wolfe
Journal:  Emerg Infect Dis       Date:  2006-04       Impact factor: 6.883

4.  Integrated Analysis of Environment, Cattle and Human Serological Data: Risks and Mechanisms of Transmission of Rift Valley Fever in Madagascar.

Authors:  Marie-Marie Olive; Véronique Chevalier; Vladimir Grosbois; Annelise Tran; Soa-Fy Andriamandimby; Benoit Durand; Jean-Pierre Ravalohery; Seta Andriamamonjy; Fanjasoa Rakotomanana; Christophe Rogier; Jean-Michel Heraud
Journal:  PLoS Negl Trop Dis       Date:  2016-07-14

5.  Integrated biological-behavioural surveillance in pandemic-threat warning systems.

Authors:  Maureen Miller; Emily Hagan
Journal:  Bull World Health Organ       Date:  2016-11-03       Impact factor: 9.408

Review 6.  How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence.

Authors:  Luke Nyakarahuka; Clovice Kankya; Randi Krontveit; Benjamin Mayer; Frank N Mwiine; Julius Lutwama; Eystein Skjerve
Journal:  BMC Infect Dis       Date:  2016-11-25       Impact factor: 3.090

7.  Acute spotted fever rickettsiosis among febrile patients, Cameroon.

Authors:  Lucy M Ndip; Donald H Bouyer; Amelia P A Travassos Da Rosa; V P K Titanji; Robert B Tesh; David H Walker
Journal:  Emerg Infect Dis       Date:  2004-03       Impact factor: 6.883

8.  Risk maps of Lassa fever in West Africa.

Authors:  Elisabeth Fichet-Calvet; David John Rogers
Journal:  PLoS Negl Trop Dis       Date:  2009-03-03

9.  Pox-like lesions and haemorrhagic fever in two concurrent cases in the Central African Republic: case investigation and management in difficult circumstances.

Authors:  Guenter Froeschl; Pitchou Kasongo Kayembe
Journal:  Pan Afr Med J       Date:  2015-09-10

10.  Yellow fever risk assessment in the Central African Republic.

Authors:  J Erin Staples; Mawlouth Diallo; Kristen B Janusz; Casimir Manengu; Rosamund F Lewis; William Perea; Sergio Yactayo; Amadou A Sall
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-06-19       Impact factor: 2.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.